Advertisement

Topics

Search Results for "New Arthritis Medication 2012"

22:57 EST 19th February 2017 | BioPortfolio

Matching Channels

Matching News

Arthritis drug boosts effectiveness of antidepressant medication

Giving severely depressed patients the arthritis drug celecoxib (Celebrex®) dramatically boosted the effectiveness of their antidepressant medication, a new study has found.

Cortisol-free rheumatoid arthritis medication also works for rare eye disease

A well-known rheumatoid arthritis medication containing the active agent adalimumab, a therapeutic human monoclonal antibody, is also effective for treating non-infectious uveitis, a rare eye disease,...

Coping with arthritis: What you do isn't associated with how much information you want

(Bentham Science Publishers) Arthritis patients were more likely to be high monitors (health detail oriented) than high blunters (health detail avoidant) in a study led by the University of North Caro...

Arthritis drug boosts effectiveness of antidepressant medication, study finds

Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.

Arthritis drug boosts effectiveness of antidepressant medication, Loyola study finds

(Loyola University Health System) Giving severely depressed patients the arthritis drug celecoxib (Celebrex®) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study...

Arthritis drug increases effectiveness of antidepressants in bipolar patients

Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.

Cortisol-free rheumatoid arthritis medication found effective for rare eye disease

A well-known rheumatoid arthritis medication containing the active agent adalimumab, a therapeutic human monoclonal antibody, is also effective for treating non-infectious uveitis, a rare eye disease....

FDA extends review period for rheumatoid arthritis treatment Baricitinib

Eli Lilly and Incyte announced that the FDA has extended the review period for the new drug application (NDA) for investigational baricitinib, a once-daily oral medication for the treatment of moderat...

Matching PubMed Articles

Associations Between Patient Characteristics and the Amount of Arthritis Medication Information Patients Receive.

Little is known about factors associated with the receipt of medication information among arthritis patients. This study explores information source receipt and associations between demographic and cl...

Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?

Rheumatoid arthritis (RA) is an autoimmune inflammatory disease which results in extensive articular and extra-articular morbidity and increased mortality from cardiovascular disease. Despite an incre...

Medication Non-Adherence in Systemic Lupus Erythematosus: A Systematic Review.

Medication non-adherence has not been well characterized in systemic lupus erythematosus (SLE). Our objective was to a conduct a systematic review of the literature examining the burden and determinan...

Medication Knowledge Among Older Adults Admitted to Home Care in Ontario During 2012-2013.

Medication use among Canadian seniors is widespread and increases with the number of comorbidities. Limited evidence exists on medication knowledge among seniors, especially in home care.

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

To evaluate non-adherence to prescribed subcutaneous biologicals in rheumatoid arthritis (RA) patients in Spain.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement